Comments

MediPharm Labs

Q: What sector and industry does MediPharm Labs (MEDIF) operate in?

MediPharm Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

MEDIFOTCQB

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$0.0431

-0.00090-2.05%

At close: -

MediPharm Labs (MEDIF) Forecast

News Earnings MediPharm Labs (MEDIF) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

MediPharm Labs (OTC:MEDIF) Stock Quotes, Forecast and News Summary

MediPharm Labs Stock (OTC: MEDIF) stock price, news, charts, stock research, profile.

Open	$0.04
Close	$0.04
Volume / Avg.	291.48K / 126.79K
Day Range	$0.04 - $0.04
52 Wk Range	0.04 - 0.07
Market Cap	$17.72M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	4.49

Recent News

CBD Pharma Co. MediPharm: 37% Increase In Q3 International Sales, 15% YoY Revenue Growth

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Thursday its third quarter financial results for the three months ended Sept. 30, 2024."Q3 2024 was a major step in the right direction towards profitability," Greg Hunter, the company's CFO, said. "Paying off our debt and rationalizing facilities, pursuing cost efficiencies while growing our higher margin international revenues are all critical elements to position us for long-term sustainable growth."

Jelena Martinovic

MediPharm Q2 Loss Narrows, Adjusted EBITDA Climbs As Gross Profit Improves Nearly 300% YoY

Cannabinoids-focused pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) announced on Wednesday financial results for the second quarter ended June 30, 2024, revealing an 8% year-over-year and 6% sequential increase to CA$10.3 million ($7.5 million). "We are very pleased with our Q2 results, showcasing substantial improvements in both revenue and profitability," David Pidduck, the company's CEO, said. "The strategic initiatives implemented, including cost reductions and operational efficiencies, are yielding positive results. We are particularly encouraged by the continued growth in our international sales and the progress in innovation of non-combustible cannabis formats."

Jelena Martinovic

This Cannabis Co With Significant Growth Potential And Other Hot Weed Stocks Soon To Report Earnings, What Investors Need To Know Now

Vext Science, Inc. (CSE: VEXT) (OTCQX: VEXTF), a cannabis operator with vertical operations in Arizona and Ohio, said it will release its financial results for the second quarter ended June 30, 2024, before the market opens on Tuesday, Aug. 20, 2024. A conference call and webcast will take place on the same day at 08:00 am Eastern Time. Auxly Cannabis Group Inc. (TSX: XLY) (OTCQB: CBWTF) will report earnings results for its second quarter ended June 30, 2024, on Thursday, Aug. 15, 2024, before the financial markets open.Cannabinoids-focused MediPharm Labs Corp. (TSX: LABS) (OTCQB: MEDIF) (FSE: MLZ) will release its second quarter financial results for the period ended June 30, 2024, before markets open on Wednesday, Aug. 14, 2024. A conference call and audio webcast will take place the same day at 8:30 am Eastern Time.

Jelena Martinovic

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	$0.04
Close	$0.04
Volume / Avg.	291.48K / 126.79K
Day Range	$0.04 - $0.04
52 Wk Range	0.04 - 0.07
Market Cap	$17.72M
P/E Ratio	-
Dividend Yield	-
Exchange	OTC
RSI	0
Short Interest	-
Days to Cover	4.49

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy MediPharm Labs (MEDIF) stock?

You can purchase shares of MediPharm Labs (OTCQB:MEDIF) through any online brokerage.

View our list of the best stock brokerages

Who are MediPharm Labs (MEDIF) competitors?

There are no as such competitors for MediPharm Labs.

What is the forecast, or price target, for MediPharm Labs (MEDIF) stock?

There is no analysis for MediPharm Labs to provide a consensus price target.

What is the current price for MediPharm Labs (MEDIF)?

The stock price for MediPharm Labs (OTCQB: MEDIF) is $0.0431 last updated December 20, 2024 at 3:56 PM EST.

Does MediPharm Labs (MEDIF) pay a dividend?

There are no upcoming dividends for MediPharm Labs.

When is MediPharm Labs (OTCQB:MEDIF) reporting earnings?

MediPharm Labs’s Q3 earnings are confirmed for Thursday, November 14, 2024.

Is MediPharm Labs (MEDIF) going to split?

There is no upcoming split for MediPharm Labs.

What sector and industry does MediPharm Labs (MEDIF) operate in?

MediPharm Labs is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Comments

MediPharm Labs

MediPharm Labs (MEDIF) Forecast

MediPharm Labs (OTC:MEDIF) Stock Quotes, Forecast and News Summary

Recent News

Financials

Compare

FAQ

How do I buy MediPharm Labs (MEDIF) stock?

Who are MediPharm Labs (MEDIF) competitors?

What is the forecast, or price target, for MediPharm Labs (MEDIF) stock?

What is the current price for MediPharm Labs (MEDIF)?

Does MediPharm Labs (MEDIF) pay a dividend?

When is MediPharm Labs (OTCQB:MEDIF) reporting earnings?

Is MediPharm Labs (MEDIF) going to split?

What sector and industry does MediPharm Labs (MEDIF) operate in?

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga